A $15 million under-absorption headwind impacted Q1 margins, with a smaller lingering effect expected in the second quarter.
Zacks.com on MSN
DXCM or MASI: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Instruments sector might want to consider either DexCom (DXCM) or Masimo (MASI). But which of these two stocks presents investors with the better value ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results